Bank of New York Mellon’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.55M | Buy |
117,351
+2,860
| +2% | +$33.9K | ﹤0.01% | 3103 |
|
|
2026
Q1 | $1.08M | Buy |
114,491
+1,404
| +1% | +$12.6K | ﹤0.01% | 3164 |
|
|
2025
Q4 | $916K | Sell |
113,087
-9,710
| -8% | -$106K | ﹤0.01% | 3292 |
|
|
2025
Q3 | $1.74M | Sell |
122,797
-2,520
| -2% | -$33.3K | ﹤0.01% | 2882 |
|
|
2025
Q2 | $1.64M | Buy |
125,317
+396
| +0.3% | +$5.44K | ﹤0.01% | 2852 |
|
|
2025
Q1 | $1.86M | Sell |
124,921
-2,600
| -2% | -$44.7K | ﹤0.01% | 2729 |
|
|
2024
Q4 | $2.32M | Sell |
127,521
-143,442
| -53% | -$1.93M | ﹤0.01% | 2698 |
|
|
2024
Q3 | $3.64M | Sell |
270,963
-33,993
| -11% | -$501K | ﹤0.01% | 2455 |
|
|
2024
Q2 | $4.22M | Buy |
304,956
+9,090
| +3% | +$144K | ﹤0.01% | 2415 |
|
|
2024
Q1 | $5.54M | Sell |
295,866
-19,775
| -6% | -$395K | ﹤0.01% | 2278 |
|
|
2023
Q4 | $7.15M | Sell |
315,641
-8,258
| -3% | -$179K | ﹤0.01% | 2188 |
|
|
2023
Q3 | $8.03M | Sell |
323,899
-14,360
| -4% | -$361K | ﹤0.01% | 2067 |
|
|
2023
Q2 | $9.5M | Sell |
338,259
-15,906
| -4% | -$395K | ﹤0.01% | 1970 |
|
|
2023
Q1 | $7.9M | Sell |
354,165
-8,484
| -2% | -$222K | ﹤0.01% | 2045 |
|
|
2022
Q4 | $9.64M | Buy |
362,649
+3,800
| +1% | +$124K | ﹤0.01% | 1963 |
|
|
2022
Q3 | $10.2M | Sell |
358,849
-8,301
| -2% | -$213K | ﹤0.01% | 1892 |
|
|
2022
Q2 | $7.65M | Sell |
367,150
-29,994
| -8% | -$562K | ﹤0.01% | 2087 |
|
|
2022
Q1 | $8.61M | Sell |
397,144
-46,803
| -11% | -$1.02M | ﹤0.01% | 2150 |
|
|
2021
Q4 | $12.3M | Sell |
443,947
-98,700
| -18% | -$2.39M | ﹤0.01% | 1985 |
|
|
2021
Q3 | $11.5M | Buy |
542,647
+15,748
| +3% | +$295K | ﹤0.01% | 2044 |
|
|
2021
Q2 | $8.7M | Sell |
526,899
-22,355
| -4% | -$341K | ﹤0.01% | 2225 |
|
|
2021
Q1 | $6.86M | Buy |
549,254
+13,196
| +2% | +$140K | ﹤0.01% | 2292 |
|
|
2020
Q4 | $4.75M | Buy |
536,058
+9,116
| +2% | +$74.2K | ﹤0.01% | 2386 |
|
|
2020
Q3 | $3.42M | Buy |
526,942
+141,246
| +37% | +$895K | ﹤0.01% | 2414 |
|
|
2020
Q2 | $2.38M | Sell |
385,696
-25,133
| -6% | -$154K | ﹤0.01% | 2578 |
|
|
2020
Q1 | $2.77M | Sell |
410,829
-19,298
| -4% | -$183K | ﹤0.01% | 2374 |
|
|
2019
Q4 | $5M | Sell |
430,127
-20,995
| -5% | -$237K | ﹤0.01% | 2346 |
|
|
2019
Q3 | $4.65M | Sell |
451,122
-19,735
| -4% | -$194K | ﹤0.01% | 2317 |
|
|
2019
Q2 | $4.42M | Buy |
470,857
+3,591
| +0.8% | +$27.6K | ﹤0.01% | 2386 |
|
|
2019
Q1 | $3.29M | Sell |
467,266
-6,108
| -1% | -$52.3K | ﹤0.01% | 2530 |
|
|
2018
Q4 | $3.47M | Buy |
473,374
+16,299
| +4% | +$137K | ﹤0.01% | 2477 |
|
|
2018
Q3 | $3.99M | Buy |
457,075
+13,832
| +3% | +$141K | ﹤0.01% | 2510 |
|
|
2018
Q2 | $4.99M | Buy |
443,243
+892
| +0.2% | +$10.6K | ﹤0.01% | 2391 |
|
|
2018
Q1 | $4.91M | Buy |
442,351
+1,344
| +0.3% | +$16.8K | ﹤0.01% | 2369 |
|
|
2017
Q4 | $5.63M | Sell |
441,007
-845
| -0.2% | -$11.2K | ﹤0.01% | 2303 |
|
|
2017
Q3 | $6.29M | Sell |
441,852
-103,953
| -19% | -$1.3M | ﹤0.01% | 2233 |
|
|
2017
Q2 | $7.05M | Buy |
545,805
+18,133
| +3% | +$234K | ﹤0.01% | 2150 |
|
|
2017
Q1 | $7.58M | Buy |
527,672
+20,405
| +4% | +$300K | ﹤0.01% | 2105 |
|
|
2016
Q4 | $7.92M | Buy |
507,267
+44,535
| +10% | +$610K | ﹤0.01% | 2079 |
|
|
2016
Q3 | $5.45M | Buy |
462,732
+91,011
| +24% | +$1.2M | ﹤0.01% | 2202 |
|
|
2016
Q2 | $5.17M | Sell |
371,721
-36,707
| -9% | -$486K | ﹤0.01% | 2196 |
|
|
2016
Q1 | $4.75M | Sell |
408,428
-29,983
| -7% | -$381K | ﹤0.01% | 2204 |
|
|
2015
Q4 | $7.18M | Buy |
438,411
+96,279
| +28% | +$1.53M | ﹤0.01% | 2014 |
|
|
2015
Q3 | $4.66M | Buy |
342,132
+56,947
| +20% | +$773K | ﹤0.01% | 2274 |
|
|
2015
Q2 | $3.62M | Buy |
285,185
+2,866
| +1% | +$32.5K | ﹤0.01% | 2559 |
|
|
2015
Q1 | $3.35M | Buy |
282,319
+2,732
| +1% | +$31.3K | ﹤0.01% | 2530 |
|
|
2014
Q4 | $3.49M | Sell |
279,587
-10,429
| -4% | -$107K | ﹤0.01% | 2507 |
|
|
2014
Q3 | $2.69M | Buy |
290,016
+6,443
| +2% | +$49.4K | ﹤0.01% | 2669 |
|
|
2014
Q2 | $1.85M | Buy |
283,573
+25,000
| +10% | +$165K | ﹤0.01% | 2947 |
|
|
2014
Q1 | $2.09M | Sell |
258,573
-7,680
| -3% | -$75.6K | ﹤0.01% | 2853 |
|
|
2013
Q4 | $2.66M | Buy |
266,253
+25,487
| +11% | +$177K | ﹤0.01% | 2707 |
|
|
2013
Q3 | $1.45M | Buy |
240,766
+3,034
| +1% | +$17.4K | ﹤0.01% | 3037 |
|
|
2013
Q2 | $1.23M | Buy |
+237,732
| New | +$1.22M | ﹤0.01% | 3071 |
|
Other funds holding CCRN
PGCM
CIEC
KIM
N
Bank of New York Mellon's CCRN Position: Q2 2026 in Review
Bank of New York Mellon increased its Cross Country Healthcare (CCRN) stake by 2.5% in Q2 2026, buying an estimated $33.9K and bringing the position to 117,351 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #3103.
Bank of New York Mellon first reported a position in CCRN in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.3M in Q4 2021. 60 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.
- Bank of New York Mellon held 117,351 shares of Cross Country Healthcare worth $1.55M as of Q2 2026.
- Bank of New York Mellon bought 2,860 Cross Country Healthcare shares in Q2 2026, an estimated $33.9K.
- Cross Country Healthcare made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3103 holding.
- Bank of New York Mellon first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's Cross Country Healthcare position peaked at $12.3M in Q4 2021.
- 60 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.